Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Promimic ABOSTO:PRO +7.65%70 EV-to-OCF is -38.62 as of Aug. 28, 2026. GuruFocus rates OSTO:PRO with a GF Score™ of 70/100 and a GF Value™ of kr32.49 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 852 Medical Devices & Instruments companies, Promimic AB ranks better than 91.78% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Promimic AB's Enterprise Value is kr139.96 Mil.
Promimic AB's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was kr-3.62 Mil. Therefore, Promimic AB's EV-to-OCF for today is -38.62.
The historical rank and industry rank for Promimic AB's EV-to-OCF or its related term are showing as below:
OSTO:PRO'
s EV-to-OCF Range Over the Past 10 Years
Min: -174.73 Med: -51.32 Max: -9.9
Current: -41.49
During the past 7 years, the highest EV-to-OCF of Promimic AB was -9.90. The lowest was -174.73. And the median was -51.32.
OSTO:PRO's EV-to-OCF is ranked better than 91.78% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: 7.88
vs OSTO:PRO: -41.49
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Promimic AB's PE Ratio (TTM) for today is calculated as:
Promimic AB's share price for today is kr9.15.
Promimic AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr2.710.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Promimic AB EV-to-OCF Related Terms
Promimic AB EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Promimic AB's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Promimic AB's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Promimic AB EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Promimic AB's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Promimic AB's EV-to-OCF falls into.
Promimic AB's current Enterprise Value is kr139.96 Mil.
Promimic AB's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-3.62 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Promimic AB (OSTO:PRO) has a EV-to-OCF of -38.62 as of Aug. 28, 2026. According to the industry distribution chart, Promimic AB ranks #70 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 8.2%.
Is Promimic AB's EV-to-OCF too high?
Promimic AB's current EV-to-OCF is -38.62. Based on the distribution chart, Promimic AB ranks #70 out of 852 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Promimic AB has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Promimic AB's EV-to-OCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Promimic AB ranks #70 out of 852 companies for EV-to-OCF. This places Promimic AB in the top 8% of its industry — outperforming the majority of peers. The industry median EV-to-OCF is 7.88. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.88, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Promimic AB's current EV-to-OCF is -38.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Promimic AB stock overvalued right now?
Based on GuruFocus' analysis, Promimic AB (OSTO:PRO) is currently considered Significantly Undervalued. The stock's GF Value™ is kr32.49, compared to a current price of kr9.15 — trading 71.8% below its estimated fair value. The current EV-to-OCF is -38.62. Promimic AB's overall GF Score™ is 70/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Promimic AB (OSTO:PRO), the current EV-to-OCF is -38.62 as of Aug. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Promimic AB (OSTO:PRO) Overvalued in 2026?
Based on GuruFocus' analysis, Promimic AB stock appears to be undervalued.
The current stock price of kr9.15 is trading 71.8% below its estimated GF Value™ of kr32.49.
GuruFocus considers Promimic AB to be Significantly Undervalued.
Key valuation signals for OSTO:PRO:
EV-to-OCF: -38.62
GF Value™: kr32.49 vs. price of kr9.15 (71.8% below fair value)
No single metric tells the full story. See the OSTO:PRO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:PRO has been successfully added to your 
